Do You Qualify for an AngioDynamics Port Catheter Lawsuit?

• The AngioDynamics Port Catheter Litigation: Involves allegations that defective port catheter systems manufactured by AngioDynamics and its subsidiary, Navilyst Medical, have caused serious harm to patients who relied on them for long-term intravenous treatment.
• Degradation of Material Causes Failures: These implantable devices (commonly used for chemotherapy, nutrition, and medication delivery) are reported to fail when the catheter material breaks down inside the body.
• LIfe Threatening Conditions: As the device weakens, patients may experience fractures, migration, or occlusion, leading to life-threatening conditions such as blood clots, severe infections, embolisms, or sepsis.
• Emergency Care: Many injuries linked to these failures have required emergency surgery, hospitalization, and extended medical care, resulting in significant medical bills and long-term complications.

Plaintiffs claim that AngioDynamics failed to:

• Address known manufacturing defects that make the catheter prone to cracking and fracturing over time.
• Adequately warn medical professionals and patients about the potential for device failure and migration.
• Disclose safety concerns that were allegedly known before and after the product’s release.
• Properly test and monitor the device’s durability under real-world clinical conditions.
• Recall or redesign defective port catheter systems despite mounting evidence of harm to affected patients.

The lawsuits further allege that AngioDynamics and Navilyst Medical placed profits ahead of patient safety by continuing to market devices with known design vulnerabilities.

• Therfore, as alleged, patients who received these implants have suffered injuries, undergone revision surgeries, and faced long-term health consequences.
• Those harmed may be eligible to pursue financial compensation for medical expenses, lost wages, and pain and suffering.